Showing results (241-250 of 280) with videos related to
Sort By:
Pageof 28
International Journal of Molecular Sciences|February 24, 2024
Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2Lucía Paniagua-Herranz, Irene Moreno, Cristina Nieto-Jiménez, et al.Journal of Crohn'S & Colitis|April 15, 2014
Risk of colectomy in patients with ulcerative colitis under thiopurine treatmentAlex Cañas-Ventura, Lucia Márquez, Elena Ricart, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 8, 2021
Prognostic models for mortality after cardiac surgery in patients with infective endocarditis: a systematic review and aggregation of prediction modelsBorja M Fernandez-Felix, Laura Varela Barca, Esther Garcia-Esquinas, et al.The European Respiratory Journal|July 27, 2022
Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE studyAndrew Menzies-Gow, Mark Gurnell, Liam G Heaney, et al.British Journal of Clinical Pharmacology|February 18, 2024
Genetic biomarkers of methotrexate response and safety in Crohn's disease: Data from the Spanish ENEIDA registryJuliana Salazar, Esther Garcia-Planella, Agnès Fernández-Clotet, et al.Journal of Endourology|August 16, 2022
Retrograde Intrarenal Surgery in Children: Evolution, Current Status, and Future TrendsYesica Quiroz, Bhaskar Kumar Somani, Yiloren Tanidir, et al.Gut|March 10, 2026
<i>Roseburia inulinivorans</i> increases muscle strengthBorja Martinez-Tellez, Milena Schönke, Artemiy Kovynev, et al.The Journal of Cell Biology|October 24, 2012
N-WASP coordinates the delivery and F-actin-mediated capture of MT1-MMP at invasive pseudopodsXinzi Yu, Tobias Zech, Laura McDonald, et al.BMJ Open Gastroenterology|April 28, 2020
Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE studyIgnacio Marin-Jimenez, Guillermo Bastida, Ana Forés, et al.The European Respiratory Journal|April 4, 2024
Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programmeDavid J Jackson, Girolamo Pelaia, Benjamin Emmanuel, et al.Pageof 28